Bailard’s Veracyte VCYT Stock Holding History

Bailard’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,200	Closed	-$334K	–	788
2021 Q3	$334K	Hold	7,200	–	–	0.01%	500
2021 Q2	$288K	Buy	+7,200	New	+$308K	0.01%	549

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bailard's VCYT Position: Q4 2021 in Review

Bailard sold out of Veracyte (VCYT) in Q4 2021, closing a stake of 7,200 shares — an estimated $334K sold.

Bailard first reported a position in VCYT in Q2 2021 and held it in 2 quarters. The position peaked at $334K in Q3 2021. 217 funds tracked by Wall St. Rank hold VCYT as of Q4 2021.

Bailard reported no remaining Veracyte position as of Q4 2021 after selling out during the quarter.
Bailard sold 7,200 Veracyte shares in Q4 2021, an estimated $334K.
Bailard first reported a position in Veracyte in Q2 2021 and held it in 2 quarters.
Bailard's Veracyte position peaked at $334K in Q3 2021.
217 funds tracked by Wall St. Rank held Veracyte as of Q4 2021.

Based on Bailard's 13F filing for Q4 2021, filed 10 Feb 2022.